HSA to review regulatory framework for complementary health products

The move will better support the development of longevity health products, while ensuring robust consumer protection. Read more at straitstimes.com.

SINGAPORE – Singapore’s Health Sciences Authority (HSA) is reviewing its regulatory framework for complementary health products, which include health supplements and traditional medicines, and anticipates finalising the regulations by mid-2028, said HSA chief executive Raymond Chua.

It will be engaging extensively with the research community, healthcare professionals and industry stakeholders to gather their insights on the framework, he said.

The move will better support the development of longevity health products, while ensuring robust consumer protection and clear regulatory pathways for emerging health products, he said in his keynote speech at the Geromedicine: Unlocking Healthy Longevity Conference on Feb 26.

Geromedicine is an emerging evidence-based field that applies the biology of ageing to clinical practice. It shifts the paradigm from treating age-related diseases to targeting ageing itself.

Organised by the NUS Academy for Healthy Longevity at the National University of Singapore’s Yong Loo Lin School of Medicine, the two-day conference aims to discuss current trends and emerging evidence in supplements and repurposed drugs that aim to optimise health and extend healthspan.

Currently, consumers can buy health supplements or traditional medicines off the shelf. Companies are responsible for ensuring that their products are not harmful.